← Leaderboards
Olga V Fedorova
Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Aging
Same institution · by research overlap
Others in their field
Top investigators on “Marinobufagenin”
- Zijian Xie · University Of Toledo Health Sci Campus$2,016,561
- David Joseph Kennedy · University Of Michigan At Ann Arbor$1,893,750
- Jiang Tian · University Of Toledo Health Sci Campus$1,484,892
- Joseph Isaac Shapiro · University Of Toledo Health Sci Campus$833,505
- James W Larrick · Panorama Research, Inc.$580,146
- Wei Li · Marshall University$498,153
Research focus
MarinobufageninNa(+)-K(+)-Exchanging AtpaseSodium ChlorideAgingBlood PressureCardiovascular SystemExhibitsMaleHypertensionCardiovascular DiseasesBlood VesselsRattusSalt IntakeExperimental StudyArterial StiffnessAlzheimer&AposPhysiologic PulseBrainDahl Hypertensive RatsFibrosisImpaired CognitionAnimal ModelAnimalsImpairment
Grant awards (24)
Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and females$1,606,197
ZIA · FY2025 · AG · contact PI
Exploring the association of Na pump ligands with vascular dysfunction and neurodegeneration in Alzheimer's disease and related dementias$437,168
ZIA · FY2025 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$1,807,527
ZIA · FY2024 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,251,365
ZIA · FY2024 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2,190,748
ZIA · FY2023 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,518,739
ZIA · FY2023 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,515,425
ZIA · FY2022 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$392,077
ZIA · FY2022 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$2,162,028
ZIA · FY2021 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$1,459,682
ZIA · FY2021 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2,565,266
ZIA · FY2020 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,851,028
ZIA · FY2020 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2,910,321
ZIA · FY2019 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,315,597
ZIA · FY2019 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2,148,046
ZIA · FY2018 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1,512,093
ZIA · FY2018 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2,920,663
ZIA · FY2017 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$888,748
ZIA · FY2017 · AG · contact PI
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$884,511
ZIA · FY2016 · AG · contact PI
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$662,681
ZIA · FY2016 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$0
Z01 · FY2006 · AG · contact PI
Sodium Pump Inhibitors In Blood Pressure Regulation$0
Z01 · FY2005 · AG
Sodium Pump Inhibitors In Blood Pressure Regulation$0
Z01 · FY2004 · AG
Sodium Pump Inhibitors In Blood Pressure Regulation$0
Z01 · FY2003 · AG